Skip to main content

Medication Treatments

An analysis of opioid use disorder treatment under Medicaid in North Carolina finds that while more patients are receiving evidence-based care, the service gap continues to widen.
Community Medical Services regional operations manager Haley Horton explained to NCAD West attendees how the organization has engaged patients in remote areas through the development of medication units as a complement to its traditional opioid treatment programs.
A life sciences company that is testing a sustained-release risperidone product for psychosis is now pursuing an effort to improve adherence to naltrexone for opioid dependence.
With fentanyl driving up overdose-related death rates among patients who relapse, formerly abstinence-based treatment programs are beginning to embrace medication-assisted treatment, says Andrew Stone, MD, MPH.
Initial research is helping to confirm Hazelden Betty Ford Foundation's move to established focused treatment for opioid addiction that includes extended medication treatment.
Back to Top